Lastly, the increase of both BACE1 and phospho-eIF2α levels in the 5XFAD transgenic mouse model of aggressive amyloid pathology [22] indicates that this animal model could be useful for studying the role of eIF2α phosphorylation in BACE1 elevation and amyloidogenesis in AD. This evidence concerns the gene BACE1 and Alzheimer disease.